Thymoquinone in Alzheimer’s disease: experimental evidence and neuroprotective mechanisms

Jamil A. Chahrour , Marwa Rammal , Zaher Abdel Baki , Akram Hijazi

Exploration of Neuroscience ›› 2026, Vol. 5 ›› Issue (1) : 1006137

PDF (942KB)
Exploration of Neuroscience ›› 2026, Vol. 5 ›› Issue (1) :1006137 DOI: 10.37349/en.2026.1006137
research-article
Thymoquinone in Alzheimer’s disease: experimental evidence and neuroprotective mechanisms
Author information +
History +
PDF (942KB)

Abstract

Thymoquinone (TQ), the main bioactive constituent of Nigella sativa, has gained great attention for its neuroprotective properties, especially for Alzheimer’s disease (AD), which is a progressive neurodegenerative disorder with limited therapeutic options. This review provides several experimental evidence on the effects of TQ in AD models. The evidences indicate that TQ reduces the amyloid-β accumulation, reduces the oxidative stress and neuroinflammation, and improves cognitive and behavioral outcomes. Additionally, TQ should be able to promote the neuronal survival and neurogenesis while reducing biological markers that indicate brain damage or neuron loss. Although these findings clearly highlight and show the promising therapeutic potential of the TQ molecule in the AD, it is important to note that further in-depth studies are still needed to fully understand its underlying molecular mechanisms and to determine its clinical relevance in patients.

Keywords

thymoquinone / Alzheimer’s disease / antioxidant

Cite this article

Download citation ▾
Jamil A. Chahrour, Marwa Rammal, Zaher Abdel Baki, Akram Hijazi. Thymoquinone in Alzheimer’s disease: experimental evidence and neuroprotective mechanisms. Exploration of Neuroscience, 2026, 5 (1) : 1006137 DOI:10.37349/en.2026.1006137

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Mohebbati R, Khazdair MR Hedayati M. Neuroprotective effects of medicinal plants and their constituents on different induced neurotoxicity methods: A review. J Rep Pharma Sci. 2017; 6:34-50.

[2]

Chahrour JA, Abdel Baki Z, El Badan D, Nasser G, Maresca M, Hijazi A. Herbal Medicines in the Management of Diabetes Mellitus: Plants, Bioactive Compounds, and Mechanisms of Action. Biomolecules. 2025; 15:1674.

[3]

Chanda S, Ramachandra TV. A review on some therapeutic aspects of phytochemicals present in medicinal plants. Int J Pharm Life Sci. 2019; 10:6052-8.

[4]

Aljabre SHM, Alakloby OM, Randhawa MA. Dermatological effects of Nigella sativa. J Dermatol Dermatol Surg. 2015; 19:92-8.

[5]

Gürel SH, Çiçek Polat D. NIGELLA SATIVA L.: AN OVERVIEW. J Fac Pharm Ankara Univ. 2024; 49:21.

[6]

Jawad MMHM, Warqa MSA, Al-Sheikh HQM, Al-Fahham AA. Clinical applications of Nigella sativa: A review article. IJHMR. 2024; 3:521-6.

[7]

Sharma NK, Ahirwar D, Jhade D, Gupta S. Medicinal and phamacological potential of Nigella sativa: A review. Ethnobotanical Leafl. 2009; 13:946-55.

[8]

Huchchannanavar S, Yogesh LN, Prashant SM. The black seed Nigella sativa: A wonder seed. Int J Chem Stud. 2019; 7:1320-4.

[9]

Thakur S, Kaurav H, Chaudhary G. Nigella sativa (Kalonji): A Black Seed of Miracle. Int J Res Rev. 2021; 8:342-57.

[10]

Balyan P, Akhter J, Kumar P, Ali A. Traditional and modern usage of Nigella sativa L. (Black cumin). AP. 2022; 11:255-65.

[11]

Shaukat A, Zaidi A, Anwar H, Kizilbash N. Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. Front Nutr. 2023; 10:1126272.

[12]

Al-Hakeem Y, Haidar Y, Abdel Baki Z, Chahrour JA, El Badan D, Nasser G, et al.Integrated Phytochemical and Functional Evaluation of Nigella sativa and Olea europaea for Nutraceutical and Cosmetic Applications. Chem Methodol. 2025; 10:326-40.

[13]

Ahmad MF, Ahmad FA, Ashraf SA, Saad HH, Wahab S, Khan MI, et al.An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. J Herb Med. 2021; 25:100404.

[14]

Abdelwahab SI, Taha MME, Mariod AA. Thymoquinone-related knowledge (1915-2022): A comprehensive bibliometric analysis. Foods Raw Mater. 2023; 11:309-20.

[15]

Goyal SN, Prajapati CP, Gore PR, Patil CR, Mahajan UB, Sharma C, et al.Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin. Front Pharmacol. 2017; 8:656.

[16]

Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, et al.Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals (Basel). 2021; 14:369.

[17]

Aslani MR, Saadat S, Boskabady MH. Comprehensive and updated review on anti-oxidant effects of Nigella sativa and its constituent, thymoquinone, in various disorders. Iran J Basic Med Sci. 2024; 27:923-51.

[18]

Dera AA, Al Fayi M, Otifi H, Alshyarba M, Alfhili M, Rajagopalan P. Thymoquinone (Tq) protects necroptosis induced by autophagy/mitophagy-dependent oxidative stress in human bronchial epithelial cells exposed to cigarette smoke extract (CSE). J Food Biochem. 2020; 44:e13366.

[19]

Farsiabi R, Khodadadi I, Karimi J, Shafiee G. Evaluation of the Effects of Thymoquinone on Oxidative Stress in A549 Lung Cancer Cell Line. Middle East J Cancer. 2023; 14:231-40.

[20]

Ahmad A, Alkharfy KM, Jan BL, Ahad A, Ansari MA, Al-Jenoobi FI, et al.Thymoquinone treatment modulates the Nrf2/HO-1 signaling pathway and abrogates the inflammatory response in an animal model of lung fibrosis. Exp Lung Res. 2020; 46:53-63.

[21]

Kundu J, Kim DH, Kundu JK, Chun KS. Thymoquinone induces heme oxygenase-1 expression in HaCaT cells via Nrf2/ARE activation: Akt and AMPKα as upstream targets. Food Chem Toxicol. 2014; 65:18-26.

[22]

El Mezayen R, El Gazzar M, Nicolls MR, Marecki JC, Dreskin SC, Nomiyama H. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett. 2006; 106:72-81.

[23]

Li B, Nasser MI, Masood M, Adlat S, Huang Y, Yang B, et al.Efficiency of Traditional Chinese medicine targeting the Nrf2/HO-1 signaling pathway. Biomed Pharmacother. 2020; 126:110074.

[24]

Rashid S. Impact of thymoquinone on the Nrf2/HO-1 and MAPK/NF-κB axis in mitigating 5-fluorouracil-induced acute kidney injury in vivo. Front Oncol. 2025; 15:1572095.

[25]

Berkoz M, Yunusoglu O, Krosniak M, Francik R. Anti-inflammatory Potential of Thymoquinone in Tumor Necrosis Factor-alpha Stimulated SW982 Human Synovial Fibroblasts. Eastern J Med. 2023; 28:644-52.

[26]

Yalçın T, Kaya S, Yiğin A, Ağca CA, Özdemir D, Kuloğlu T, et al.The Effect of Thymoquinone on the TNF-α/OTULIN/NF-κB Axis Against Cisplatin-İnduced Testicular Tissue Damage. Reprod Sci. 2024; 31:2433-46.

[27]

Bargi R, Hosseini M, Asgharzadeh F, Khazaei M, Shafei MN, Beheshti F. Protection Against Blood-Brain Barrier Permeability as a Possible Mechanism for Protective Effects of Thymoquinone Against Sickness Behaviors Induced by Lipopolysaccharide in Rats. Jundishapur J Nat Pharm Prod. 2021; 16:e67765.

[28]

Khader M, Eckl PM. Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci. 2014; 17:950-7.

[29]

Salim LZ, Mohan S, Othman R, Abdelwahab SI, Kamalidehghan B, Sheikh BY, et al.Thymoquinone induces mitochondria-mediated apoptosis in acute lymphoblastic leukaemia in vitro. Molecules. 2013; 18:11219-40.

[30]

Salem ML, Hossain MS. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int J Immunopharmacol. 2000; 22:729-40.

[31]

Seadawy M. Natural Compounds (Thymol, Carvacrol, Hesperidine, and Thymoquinone) Against SARS-CoV-2 Strain Isolated From Egyptian Patients.Research Square 101405 [Preprint]. c2020 [cited 2026 Mar 7]. Available from: https://doi.org/10.21203/rs.3.rs-101405/v1

[32]

Zihlif MA, Mahmoud IS, Ghanim MT, Zreikat MS, Alrabadi N, Imraish A, et al.Thymoquinone efficiently inhibits the survival of EBV-infected B cells and alters EBV gene expression. Integr Cancer Ther. 2013; 12:257-63.

[33]

Ulasli M, Gurses SA, Bayraktar R, Yumrutas O, Oztuzcu S, Igci M, et al.The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol Biol Rep. 2014; 41:1703-11.

[34]

Samra R, Zaki A, Shaker M, Maatooq G. Occurrence and Bioactivity Diversity of Thymoquinone: An Overview. Octahedron Drug Res. 2022; 1:665-84.

[35]

Aljabre SH, Randhawa MA, Akhtar N, Alakloby OM, Alqurashi AM, Aldossary A. Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J Ethnopharmacol. 2005; 101:116-9.

[36]

Singh RK. Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches. Curr Neuropharmacol. 2020; 18:868-82.

[37]

Farkhondeh T, Samarghandian S, Shahri AMP, Samini F. The Neuroprotective Effects of Thymoquinone: A Review. Dose Response. 2018; 16:1559325818761455.

[38]

Elibol B, Terzioglu-Usak S, Beker M, Sahbaz C. Thymoquinone (TQ) demonstrates itsneuroprotective effect via an anti-inflammatoryaction on the Aβ(1–42)-infused rat model ofAlzheimer’s disease. Psychiatry Clin Psychopharmacol. 2019; 29:379-86.

[39]

Ismail N, Ismail M, Shahid I, Latiffah AL. Anti-aggregation effects of thymoquinone against Alzheimer’s β-amyloid in vitro. J Med Plants Res. 2013; 7:2280-8.

[40]

Fiasal Zaher M, Abdelfattah Bendary M, Saeed Abd El-Aziz G, Shaker Ali A. Potential Protective Role of Thymoquinone on Experimentally-induced Alzheimer Rats. JPRI. 2019; 31:1-18.

[41]

Poorgholam P, Yaghmaei P, Hajebrahimi Z. Thymoquinone recovers learning function in a rat model of Alzheimer’s disease. Avicenna J Phytomed. 2018; 8:188-97.

[42]

Orellana-Urzúa S, Rojas I, Líbano L, Rodrigo R. Pathophysiology of Ischemic Stroke: Role of Oxidative Stress. Curr Pharm Des. 2020; 26:4246-60.

[43]

Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem. 2015; 97:55-74.

[44]

Abbas F, Eladl MA, El-Sherbiny M, Abozied N, Nabil A, Mahmoud SM, et al.Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: Behavioral psychomotor performance, neurotransmitter level, oxidative-inflammatory markers, and BDNF expression in rat brain. Biomed Pharmacother. 2022; 151:113072.

[45]

Kantar D, Acun AD, Danışman B. Effects of thymoquinone on scopolamine-induced spatial and echoic memory changes through regulation of lipid peroxidation and cholinergic impairment. Behav Brain Res. 2022; 431:113972.

[46]

Farkhondeh T, Samarghandian S, Azimin-Nezhad M, Samini F. Effect of chrysin on nociception in formalin test and serum levels of noradrenalin and corticosterone in rats. Int J Clin Exp Med. 2015; 8:2465-70.

[47]

Al-Damook N, Sakkal M, Khair M, Mousa WK, Khoder G, Ghemrawi R. Targeting Cancer Through Thymoquinone: From Molecular Mechanisms to Clinical Prospects. Int J Mol Sci. 2025; 26:11029.

[48]

Alhmied F, Alammar A, Alsultan B, Alshehri M, Pottoo FH. Molecular Mechanisms of Thymoquinone as Anticancer Agent. Comb Chem High Throughput Screen. 2021; 24:1644-53.

[49]

Majdalawieh AF, Al-Samaraie S, Terro TM. Molecular Mechanisms and Signaling Pathways Underlying the Therapeutic Potential of Thymoquinone Against Colorectal Cancer. Molecules. 2024; 29:5907.

PDF (942KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/